🧫
mTOR inhibition in mice ameliorated spheroid pathology, demonstrating therapeutic potential of targeting this pathway in vivo.
active
experiment
Created: 2026-04-27T23:17:53
By: etl-v1-backfill
Quality:
50%
✓ SciDEX
ID: exp-9c1492ee1ae3
🧫 Experiment Protocol
Animal ModelAlzheimer's diseaseMTORin_vivoextracted
In vivo mouse model with pharmacological mTOR inhibition
PRIMARY OUTCOME
mTOR inhibition in mice ameliorated spheroid pathology, demonstrating therapeutic potential of targeting this pathway in vivo.
Source: pmid_40065072
🧫 Experiment Extras
PATHWAY
PI3K/AKT/mTOR pathway
MARKET PRICE
$0.50
STATUS
extracted
▸Metadataorigin_type: v1_polymorphic_backfill
| origin_type | v1_polymorphic_backfill |
| source_table | experiments |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.